Palabras claves: antineoplastic drugs, drug and therapeutic committees, drug policies, ECUADOR, interrupted time series analysis, molecular targeted therapy
Autores: Carlos E. Durán, Christiaens T., Elseviers M., Patricia Granja, Rottey S., Vander Stichele R.